Enhanced SLAMF7 homotypic interactions by elotuzumab improves NK cell killing of multiple myeloma

Tatiana Pazina, Ashley M. James, Kimberly B. Colby, Yibin Yang, Andrew Gale, Amy Jhatakia, Alper Y. Kearney, Robert F. Graziano, Natalie A. Bezman, Michael D. Robbins, Adam D. Cohen, Kerry S. Campbell

Cancer Signaling and Microenvironment (CSM)
Center for Immunology
Greenberg Pancreatic Cancer Institute

Fox Chase Cancer Center
Russian Academy of Medical Sciences - Institute of Experimental Medicine
Bristol-Myers Squibb
University of Pennsylvania

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

3 results
- Title(descending)

Cell Culture Facility
Campbell, PhD, K. S. (Director) & Yan PhD , Y. (Manager)
Equipment/facility: Facility
Cell Sorting Facility
Campbell, PhD, K. S. (Director), Font-Burgada, PhD, J. (Director), MacFarlane, PhD, A. (Manager) & Oesterling, BS, J. (Manager)
Equipment/facility: Facility
High Throughput Screening Facility
Golemis, PhD, E. A. (Director) & Einarson, PhD, M. B. (Manager)
Equipment/facility: Facility

Enhanced SLAMF7 homotypic interactions by elotuzumab improves NK cell killing of multiple myeloma

Equipment

Search results

Cell Culture Facility

Cell Sorting Facility

High Throughput Screening Facility